By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer


Educational Events

Cutting-Edge Research on Triple-Negative Breast Cancer

Researchers from the University of Arizona have developed a drug compound that appears to stop cancer cell growth in what's known as triple-negative breast cancer. The drug, which has not yet been tested in humans, has been shown to eliminate tumors in mice, with little to no effect on normal healthy cells, making it potentially nontoxic for patients. The therapy is based on a newly discovered way that a gene known as epidermal growth factor receptor, or EGFR, leads to cancer. EGFR is a long-investigated oncogene—a gene that in certain circumstances can transform a cell into a tumor cell.

Join our facilitator Nancy Touhill as she speaks with a researcher to breakdown this information for the TNBC community. 




Key Topic(s):

Tuesday, March 21st, at 6:00PM EST


  • TNBC breast cancer patients
  • The latest in drug therapy research on TNBC

To register click here.



Your path to accessing financial resources

Quick Find

Our Stories


See our calendar